Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19 Vaccines and Treatments AN OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE The U.S. House of Representatives Committee on Energy and Commerce is scheduled to hold a hearing with Big Pharma executives on Tuesday, February 23. Executives for brand name drug giants including Pfizer, Moderna, Johnson […]
Analysis Finds Drug Companies Posted Banner Year For Profits and Mergers While Hiking Drug Prices During Pandemic A new report on the pharmaceutical industry from research firm Evaluate Vantage lays out in detail the blockbuster year Big Pharma had in 2020, while the industry repeatedly raised prescription drug prices amid the COVID-19 pandemic. From ballooning […]
Brand Name Pharma Companies Continue to Bring in Sky-High Profits While Hiking Prices New fourth quarter earning reports from Big Pharma giants Bristol-Myers Squibb (BMS), Sanofi, Merck, Roche and AstraZeneca demonstrate yet again that price hikes continue to support big time profits for brand name drug companies. All five drug makers reported sky-high earnings after […]
Study Finds Solutions to Make Medications More Accessible Will Not Restrict R&D and Breakthrough Cures A new report from Patients for Affordable Drugs (P4AD), “Big Pharma’s Big Lie: The Truth About Innovation and Drug Pricing,” debunks Big Pharma’s bogus rhetoric that any action to curb the industry’s price-gouging and anti-competitive tactics will stifle innovation and […]
Brand Name Pharma Giants Surpass Expectations While Hiking Prices During Pandemic New fourth quarter earnings reports released this week from Big Pharma giants GlaxoSmithKline (GSK) and AbbVie demonstrate yet again that price hikes continue to support expectation-busting profits for brand name drug companies. Both pharmaceutical manufacturers beat Wall Street expectations for the fourth quarter of […]
Big Pharma Giants See Profits Jump After New Year Price Hikes New earnings reports for the fourth quarter of 2020 show that Big Pharma giants are continuing to rake in big profits while hiking prescription drug prices during the pandemic. On Tuesday, Pfizer and Amgen announced earnings for the fourth quarter of 2020 that bested […]
Brand Name Drug Company Sees Soaring Profits After Hiking Prices Today, brand name drug giant Eli Lilly announced rising profits for the fourth quarter of 2020 – topping analysts’ expectations. The company clocked $7.44 billion in revenue for Q4 – surpassing analysts’ expectations. Stock for Eli Lilly surged to a ‘record high’ driven by strong […]
New RAND Report Finds Rx Prices in U.S. Average 3.44 Times Higher Than Those in 32 Other Countries In case you missed it, a new report from the RAND Corporation finds that prescription drug prices in the United States average a whopping 3.44 times higher than those seen in 32 other countries. According to Andrew […]
CSRxP Briefing Covers Impact of Affordability Crisis, Drug Company’s Price-Hiking Practices and Bipartisan, Market-Based Solutions The Campaign for Sustainable Rx Pricing (CSRxP) hosted a briefing, “Prescription for Change: Why Drug Prices Are Out-of-Control and How to Fix It,” on Wednesday. CSRxP was joined for the briefing by a panel of leaders representing hospitals, physicians, health […]
Price Hikes Fuel Sky-High Earnings For Brand Name Giants As millions of Americans continue to grapple with the economic impact of the COVD-19 pandemic, the first earnings reports for the fourth quarter of 2020 from Big Pharma demonstrate that hiking prices on American patients continues to be a profitable practice for the industry. Yesterday, brand […]